Drug intelligence / Profile preview

mahanine

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

**Mahanine** is a natural carbazole alkaloid isolated primarily from the leaves of the edible plant **Murraya koenigii**. It has shown **potent anticancer activity** against various cancer cell lines (breast cancer, prostate cancer, and leukemia) via induction of apoptosis and cell cycle arrest, partly mediated by mitochondrial membrane depolarization and caspase-3 activation. Additionally, mahanine reverses epigenetic silencing (e.g., RASSF1A in prostate cancer), inhibits cancer stem cell self-renewal, and disrupts growth and survival pathways such as JAK/STAT, Src, PI3K/Akt, and p53. Mahanine also demonstrates **antileishmanial activity** via oxidative stress, modulation of the STAT pathway, and upregulation of nitric oxide production, with efficacy in both in vitro and in vivo models. Chemical formula: **C23H25NO2**. Mechanism of action includes DNA minor groove binding, modulation of apoptosis and cell cycle regulators, inhibition of DNMT activity, and alteration of cytokine signaling in immune cells[1][3][5][6][7][9][11].

Other names
(-)-mahanine(R)-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-3,11-dihydropyrano[3,2-a]carbazol-9-ol28360-49-8(-)-mahaninmahanineKBJ2W7E9BHKBJ-2W7E9BHKBJ 2W7E9BH
02

Targets

HSP90 (Heat shock protein 90 chaperone complex)bc1 complex (Cytochrome bc1 complex (plasmodium))DNA

Beyond the preview

Go deeper on mahanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mahanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call